China Pharma Holdings (CPHI) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Price: $1.13 +3.67%
Financial Fact:
Interest expense: -213.74K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest expense: -213.74K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q1 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $18.1 million versus the consensus estimate of $18 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
